Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.
CME commentary: GLP-1 receptor agonists to prevent major cardiovascular adverse events (MACE) in type 2 diabetes (T2D), cardiovascular disease (CVD)
CCO downloadable PDF: Evidence and expert answers on continuous glucose monitoring (CGM)
Expert slideset with recommendations on selecting optimal continuous glucose monitoring (CGM) devices for patients with diabetes, from CCO
Short CME/CE-certified video from CCO: Expert insights on when and how to integrate continuous glucose monitoring (CGM) into care of patients with diabetes
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.